Your browser is no longer supported. Please, upgrade your browser.
Settings
HTGM HTG Molecular Diagnostics, Inc. daily Stock Chart
HTGM [NASD]
HTG Molecular Diagnostics, Inc.
Index- P/E- EPS (ttm)-2.55 Insider Own4.00% Shs Outstand13.67M Perf Week47.52%
Market Cap69.17M Forward P/E- EPS next Y-1.28 Insider Trans-69.28% Shs Float11.15M Perf Month48.82%
Income-22.70M PEG- EPS next Q-0.40 Inst Own17.20% Short Float16.62% Perf Quarter142.11%
Sales8.30M P/S8.33 EPS this Y27.20% Inst Trans17.43% Short Ratio1.18 Perf Half Y136.45%
Book/sh-0.39 P/B- EPS next Y39.90% ROA-136.20% Target Price5.50 Perf Year170.59%
Cash/sh0.66 P/C7.69 EPS next 5Y- ROE401.60% 52W Range1.20 - 13.25 Perf YTD149.26%
Dividend- P/FCF- EPS past 5Y- ROI-164.50% 52W High-61.81% Beta-
Dividend %- Quick Ratio0.90 Sales past 5Y- Gross Margin41.60% 52W Low321.67% ATR0.54
Employees87 Current Ratio1.00 Sales Q/Q311.10% Oper. Margin- RSI (14)73.43 Volatility21.49% 13.35%
OptionableNo Debt/Eq- EPS Q/Q49.60% Profit Margin- Rel Volume1.32 Prev Close5.05
ShortableYes LT Debt/Eq- EarningsMar 22 AMC Payout- Avg Volume1.57M Price5.06
Recom1.50 SMA2030.73% SMA5068.32% SMA20091.46% Volume2,078,766 Change0.20%
May-16-17Reiterated Rodman & Renshaw Buy $4.50 → $6
Aug-22-16Initiated Rodman & Renshaw Buy $5
Apr-04-16Reiterated Canaccord Genuity Buy $10 → $7
Nov-24-15Reiterated Canaccord Genuity Buy $12 → $10
Aug-24-15Reiterated Canaccord Genuity Buy $17 → $12
Jun-03-15Initiated JMP Securities Mkt Outperform
Jun-02-15Initiated Leerink Partners Outperform $18
Jun-02-15Initiated Canaccord Genuity Buy $17
Feb-07-18 08:00AM  HTG Molecular Diagnostics to Present at the LEERINK Partners 7th Annual Global Healthcare Conference GlobeNewswire
Jan-23-18 04:01PM  HTG Molecular Diagnostics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters Option to Purchase Additional Shares GlobeNewswire
Jan-18-18 07:29PM  HTG Molecular Diagnostics Announces Pricing of Public Offering of Common Stock GlobeNewswire +18.88%
Jan-17-18 07:55AM  New Research Coverage Highlights HTG Molecular Diagnostics, Momenta Pharmaceuticals, Black Knight Financial Services, Verint, IBERIABANK, and Sterling Construction Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire -18.29%
Jan-16-18 04:01PM  HTG Molecular Diagnostics Announces Proposed Public Offering of Common Stock GlobeNewswire
08:00AM  HTG Molecular Announces Third Statement of Work for New Clinical Assay Development Program GlobeNewswire
Jan-05-18 08:10AM  Todays Research Reports on Trending Tickers: HTG Molecular Diagnostics and Omeros Corporation ACCESSWIRE -13.90%
Jan-04-18 04:30PM  Can HTG Molecular Diagnostics Inc (NASDAQ:HTGM) Improve Your Portfolio Returns? Simply Wall St. +75.98%
08:00AM  HTG Announces Preliminary Fourth Quarter and Full Year 2017 Unaudited Financial Results and Provides Initial 2018 Revenue Guidance GlobeNewswire
Dec-29-17 12:09PM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : December 29, 2017 Capital Cube
Dec-27-17 01:18PM  HTG Molecular's Deal With Merck KGaA 'Provides Further Validation' For EdgeSeq Technology Benzinga +6.70%
Dec-26-17 05:08PM  7 Stocks Moving In Tuesday's After-Hours Session Benzinga
04:01PM  HTG Molecular Diagnostics Expands its Collaboration with Merck KGaA, Darmstadt, Germany GlobeNewswire
Dec-20-17 08:00AM  HTG Molecular Diagnostics to Participate in Corporate Access Event in San Francisco, January 8 10, 2018 GlobeNewswire
Dec-18-17 03:43PM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : December 18, 2017 Capital Cube
Dec-05-17 06:15PM  Should You Be Content With HTG Molecular Diagnostics Incs (HTGM) 34.3% Earnings Growth? Simply Wall St.
12:59PM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : December 5, 2017 Capital Cube
Nov-21-17 12:59PM  Should You Be Concerned About HTG Molecular Diagnostics Incs (HTGM) Investors? Simply Wall St.
Nov-20-17 12:40PM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : November 20, 2017 Capital Cube
Nov-09-17 09:43AM  HTG Molecular Diagnostics, Inc. :HTGM-US: Earnings Analysis: Q3, 2017 By the Numbers : November 9, 2017 Capital Cube -6.67%
08:10AM  Todays Research Reports on Stocks to Watch: Ophthotech Corporation and HTG Molecular Diagnostics ACCESSWIRE
Nov-08-17 06:16PM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : November 8, 2017 Capital Cube +13.84%
Nov-07-17 04:05PM  HTG Molecular Diagnostics Reports 2017 Third Quarter Earnings GlobeNewswire -8.57%
10:30AM  HTG Molecular Diagnostics, Inc. to Host Earnings Call ACCESSWIRE
Oct-20-17 08:30AM  HTG Molecular Diagnostics to Announce Third Quarter 2017 Financial Results and Host Conference Call on Tuesday, November 7 GlobeNewswire
Oct-06-17 08:00AM  Today's Research Reports on Trending Tickers: Ionis Pharmaceuticals and HTG Molecular Diagnostics ACCESSWIRE -8.74%
Sep-25-17 08:00AM  HTG Molecular Diagnostics to Present at the Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-21-17 01:57PM  Should You Have HTG Molecular Diagnostics Incs (HTGM) In Your Portfolio? Simply Wall St. -5.64%
Sep-20-17 08:00AM  HTG Announces Issuance of Two Method Patents Related to its Technology GlobeNewswire +5.98%
Sep-18-17 08:00AM  HTG Molecular Diagnostics Receives ISO 13485 Certification for Health Canada CMDCAS Requirements GlobeNewswire
Sep-11-17 08:00AM  HTG Molecular Diagnostics Provides Regulatory Update for its HTG EdgeSeq ALKPlus Assay GlobeNewswire
Sep-06-17 08:00AM  HTG Molecular Diagnostics to Present at the Rodman & Renshaw 19th Annual Investment Conference GlobeNewswire -7.07%
Sep-05-17 08:00AM  Today's Research Reports on Trending Tickers: DryShips Inc. and Seadrill Ltd. ACCESSWIRE
Aug-31-17 06:49PM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : August 31, 2017 Capital Cube
Aug-25-17 10:38AM  HTG Molecular Diagnostics, Inc. :HTGM-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017 Capital Cube
Aug-09-17 03:43PM  Edited Transcript of HTGM earnings conference call or presentation 8-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
08:00AM  HTG Molecular Diagnostics Technology to be Used in WIN Consortium NSCLC Clinical Trial GlobeNewswire
Aug-08-17 04:01PM  HTG Molecular Diagnostics Reports Second Quarter 2017 Results GlobeNewswire
10:30AM  Investor Network: HTG Molecular Diagnostics, Inc. to Host Earnings Call ACCESSWIRE
Aug-03-17 08:26PM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : August 4, 2017 Capital Cube
Jul-27-17 09:00AM  HTG Molecular Diagnostics Announces Second Companion Diagnostic Development Project with QIAGEN GlobeNewswire
Jul-26-17 04:01PM  HTG Molecular Diagnostics to Present at the Canaccord Genuity Growth Conference GlobeNewswire
Jul-18-17 04:01PM  HTG Molecular Diagnostics to Hold 2017 Second Quarter Financial Results Conference Call on August 8, 2017 GlobeNewswire -8.36%
Jun-28-17 04:01PM  HTG Molecular Diagnostics Launches its HTG EdgeSeq PATH Assay GlobeNewswire +12.18%
Jun-26-17 08:00AM  HTG Molecular Diagnostics Participating in WIN 2017 Symposium GlobeNewswire
Jun-22-17 08:00AM  HTG Molecular New Technology, Financials, and Price Targets Accesswire
Jun-20-17 03:01PM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : June 20, 2017 Capital Cube
Jun-16-17 08:00AM  Today's Research Reports on Stocks to Watch: HTG Molecular Diagnostics and Interpace Diagnostics Group Accesswire -9.62%
Jun-05-17 08:00AM  HTG Molecular Diagnostics Expands Its IVD Agreement With Illumina to Increase the Number of Test Kits GlobeNewswire
May-19-17 10:34AM  HTG Molecular Diagnostics, Inc. :HTGM-US: Earnings Analysis: Q1, 2017 By the Numbers : May 19, 2017 Capital Cube
May-16-17 04:43PM  Edited Transcript of HTGM earnings conference call or presentation 15-May-17 8:30pm GMT Thomson Reuters StreetEvents
12:53PM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : May 16, 2017 Capital Cube
May-15-17 04:01PM  HTG Molecular Diagnostics Reports First Quarter 2017 Results GlobeNewswire
03:00PM  Investor Network: HTG Molecular Diagnostics, Inc. to Host Earnings Call Accesswire
May-04-17 08:30AM  HTG Molecular Diagnostics Introduces HTG EdgeSeq PATH Assay to Launch in Second Quarter 2017 GlobeNewswire -11.21%
May-01-17 04:01PM  HTG Molecular Diagnostics to Hold 2017 First Quarter Results Conference Call on May 15, 2017 GlobeNewswire
03:59PM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : May 1, 2017 Capital Cube
Apr-24-17 08:00AM  HTG Molecular Diagnostics and Instituto Valenciano de Oncología Initiate Breast Cancer Recurrence Risk Collaboration GlobeNewswire
Apr-17-17 04:01PM  HTG Molecular Diagnostics Transfers Listing to The Nasdaq Capital Market GlobeNewswire
12:55PM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : April 17, 2017 Capital Cube
08:00AM  HTG Molecular Diagnostics and Centre Léon Bérard Enter Into Molecular Profiling Research Agreement GlobeNewswire
07:30AM  HTG Molecular Diagnostics and Daiichi Sankyo Complete Master Services Agreement GlobeNewswire
Apr-05-17 04:52PM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : April 5, 2017 Capital Cube
Apr-04-17 09:15AM  Today's Research Reports on Stocks to Watch: TearLab and HTG Molecular Diagnostics Accesswire -10.37%
Mar-30-17 10:21AM  The Bears Continue to Be Frustrated TheStreet.com +11.60%
Mar-29-17 01:04PM  HTG MOLECULAR DIAGNOSTICS, INC Financials -10.27%
12:49PM  HTG Molecular Diagnostics, Inc. :HTGM-US: Earnings Analysis: Q4, 2016 By the Numbers : March 29, 2017 Capital Cube
10:21AM  HTG Molecular Diagnostics, Inc. :HTGM-US: Earnings Analysis: 2016 By the Numbers : March 29, 2017
Mar-28-17 06:07AM  HTG MOLECULAR DIAGNOSTICS, INC Files SEC form 8-K, Regulation FD Disclosure -23.56%
Mar-24-17 02:46PM  HTG Molecular's Shares Soar 450% the Past Two Days The Wall Street Journal +145.55%
09:30AM  Advances in Healthcare Technology and Osteoarthritis Drug Therapies Propel Two Healthcare Stocks Accesswire
09:21AM  Edited Transcript of HTGM earnings conference call or presentation 23-Mar-17 9:00pm GMT Thomson Reuters StreetEvents
Mar-23-17 05:00PM  HTG Molecular Diagnostics Inc Earnings Call scheduled for 5:00 pm ET today +83.64%
04:07PM  HTG MOLECULAR DIAGNOSTICS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement
04:03PM  HTG Molecular Diagnostics Reports Fourth Quarter and Full Year 2016 Results GlobeNewswire
04:01PM  HTG Molecular Diagnostics Completes Initial Technical Feasibility Testing with QIAGEN GeneReader NGS System GlobeNewswire
12:10PM  HTG Molecular Cancer Diagnostic Test Gets CE Mark Investopedia
10:05AM  How a Key European Decision Is Making All the Difference at HTG
07:56AM  HTG Molecular's stock soars again after CE mark obtained for assay used in lung tumor analysis at MarketWatch
07:07AM  Q4 2016 HTG Molecular Diagnostics Inc Earnings Release - After Market Close
Mar-22-17 04:01PM  HTG Molecular Diagnostics Obtains CE Mark for its HTG EdgeSeq ALKPlus Assay EU GlobeNewswire +8.63%
Mar-21-17 07:00AM  HTG Molecular Diagnostics to Hold 2016 Fourth Quarter and Full Year Financial Results Conference Call on March 23, 2017 GlobeNewswire -7.94%
Mar-07-17 04:20PM  HTG Molecular Diagnostics Appoints New Chair of the Board of Directors GlobeNewswire -8.55%
04:01PM  HTG MOLECULAR DIAGNOSTICS, INC Files SEC form 8-K, Change in Directors or Principal Officers
Feb-27-17 07:00AM  HTG Molecular Diagnostics Unveils New Direct-Target Sequencing Chemistry to Launch in First Quarter 2017 GlobeNewswire +158.54%
Feb-21-17 04:01PM  HTG MOLECULAR DIAGNOSTICS, INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule
Jan-05-17 04:01PM  HTG Molecular Diagnostics Completes Module Three Filing for HTG EdgeSeq ALKPlus Assay PMA GlobeNewswire -5.12%
Dec-16-16 11:45AM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : December 16, 2016
Dec-02-16 12:33PM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : December 2, 2016
Nov-18-16 11:13AM  HTG Molecular Diagnostics, Inc. :HTGM-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016
Nov-17-16 06:10AM  HTG MOLECULAR DIAGNOSTICS, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of E
Nov-16-16 08:30AM  HTG Molecular Diagnostics and QIAGEN Team Up to Advance Precision Diagnostics GlobeNewswire +11.73%
Nov-14-16 04:30PM  HTG Molecular Diagnostics Inc Earnings Call scheduled for 4:30 pm ET today
04:17PM  HTG MOLECULAR DIAGNOSTICS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement
04:01PM  HTG Molecular Diagnostics Reports Third Quarter 2016 Results GlobeNewswire
07:07AM  Q3 2016 HTG Molecular Diagnostics Inc Earnings Release - After Market Close
Nov-03-16 04:01PM  HTG Molecular Diagnostics to Hold 2016 Third Quarter Financial Results Conference Call on November 14, 2016 GlobeNewswire -5.24%
Nov-02-16 04:01PM  HTG Molecular Diagnostics to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum GlobeNewswire -5.41%
Nov-01-16 12:03PM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : November 1, 2016
Oct-18-16 10:32AM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : October 18, 2016 -12.33%
HTG Molecular Diagnostics, Inc. develops and markets products and services based on proprietary technology that facilitates the routine use of targeted molecular profiling. The company's products, HTG Edge and HTG EdgeSeq platforms include instrumentation (or platforms), consumables comprising assay kits, and software analytics that automate sample processing and profiles various molecular targets from samples a fraction of the size required by prevailing technologies. Its platforms generate a molecular profiling library for detection using next-generation sequencing. The company's assay product offerings include HTG EdgeSeq oncology biomarker panel; HTG EdgeSeq immuno-oncology assay; HTG EdgeSeq lymphoma panel; HTG EdgeSeq microRNA whole-transcriptome assay; and HTG EdgeSeq DLBCL cell of origin assay. It also provides sample processing and molecular profiling of retrospective cohorts through its VERI/O laboratory; and designs custom panels for biopharmaceutical customers and research services, resulting from research and development collaboration agreements with biopharmaceutical customers. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. The company has a research collaboration with Insituto Valenciano de Oncologia on breast cancer recurrence risk. HTG Molecular Diagnostics, Inc. distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McMeans Shaun DVP, Finance & Admin. & CFODec 01Sale2.119451,99242,303Dec 01 04:22 PM
McMeans Shaun DVP, Finance & Admin. & CFONov 01Sale2.269452,13643,248Nov 03 04:18 PM
McMeans Shaun DVP, Finance & Admin. & CFOOct 16Sale2.279462,14844,193Oct 18 04:15 PM
Novo Holdings A/S10% OwnerAug 25Sale1.75720,2141,260,5910Aug 25 07:17 PM
Novo Holdings A/S10% OwnerAug 24Sale1.91382,437729,919720,214Aug 25 07:17 PM
Novo Holdings A/S10% OwnerAug 23Sale2.0247,16295,4751,102,651Aug 25 07:17 PM
Novo Holdings A/S10% OwnerAug 22Sale2.0112,64125,4121,199,599Aug 22 07:25 PM
Novo Holdings A/S10% OwnerAug 21Sale2.0212,84525,9761,212,240Aug 22 07:25 PM
Novo Holdings A/S10% OwnerAug 18Sale2.1055,100115,6001,225,085Aug 22 07:25 PM
GLAXOSMITHKLINE PLCFormer 10% OwnerMar 27Sale10.15300,0003,045,180792,781Mar 29 04:04 PM